Transition report pursuant to Rule 13a-10 or 15d-10

Consolidated Balance Sheets (Parenthetical)

v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Dec. 31, 2013
Jan. 31, 2013
Consolidated Balance Sheets    
Accounts receivable, allowance (in dollars) $ 1,272 $ 761
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 195,395,940 172,506,051
Common stock, shares outstanding 195,395,940 172,506,051